See All Slides - tctmd.com

Slides

Presentation TCT 2014

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ran Kornowski

September 15, 2014

Presentation TCT 2014

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Mark C. Bates

September 15, 2014

Presentation TCT 2014

Cell Therapy to Reverse Remodel the Failing Heart: State of the Art

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Timothy D. Henry

September 15, 2014

Presentation TCT 2014

Embrella Deflector Device -Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

September 15, 2014

Presentation TCT 2014

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

The Drug-Filled Stent: From Concept to Clinical Development

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman

September 15, 2014

Presentation TCT 2014

Tissue Replacement Will Be Required!

Presenter: Francisco Fdez-Aviles

September 15, 2014

Presentation TCT 2014

Choice of Metallic DES Stents for Bifurcation Stenting

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Francesco Burzotta

September 15, 2014

Presentation TCT 2014

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Harvey D. White

September 15, 2014

Presentation TCT 2014

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider

September 15, 2014

Advertisement

Slides

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension: Vascular Dynamics

Cell Therapy to Reverse Remodel the Failing Heart: State of the Art

Embrella Deflector Device -Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

The Drug-Filled Stent: From Concept to Clinical Development

Tissue Replacement Will Be Required!

Choice of Metallic DES Stents for Bifurcation Stenting

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content